The Microbiota–Endometriosis Axis: An Immune–Endocrine Integration Model and Emerging Therapeutic Targets
International Journal of Molecular Sciences · 28.05.2026 · 27 (11) · 4883
DOI: 10.3390/ijms27114883 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.05.2026. Verfasst von Georgiana Nemeti und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400015 Cluj-Napoca, Romania. Hauptthemen laut MEDLINE: Endometriosis, Microbiota. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 244 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Endometriosis is a chronic, estrogen-dependent inflammatory disorder characterized by the ectopic implantation and persistence of endometrial-like tissue outside the uterine cavity. Despite its high prevalence and significant impact on quality of life, the pathogenesis of endometriosis remains incompletely understood and involves a complex interplay between hormonal dysregulation, immune dysfunction, and chronic inflammation. In recent years, growing evidence has highlighted the role of the microbiota as a potential modulator of these interconnected pathways. This review proposes an integrative framework in which the microbiota acts as a central modulator of immune–endocrine interactions in endometriosis, while synthesizing current evidence on underlying biological mechanisms. We discuss how alterations in the gut, vaginal, and endometrial microbiota contribute to disease pathophysiology through multiple mechanisms, including disruption of intestinal barrier integrity, activation of pro-inflammatory signaling pathways, immune dysregulation, and modulation of estrogen metabolism via the estrobolome. Microbial β-glucuronidase activity and enterohepatic recirculation of estrogens are explored as key processes linking gut dysbiosis to the hyperestrogenic environment characteristic of endometriosis. Furthermore, we review current pharmacological treatments and highlight their limitations, emphasizing the need for novel therapeutic strategies targeting upstream disease mechanisms. Emerging approaches, including probiotics, postbiotics, short-chain fatty acids, and dietary interventions, are discussed as promising adjunctive therapies capable of modulating inflammation, immune responses, and metabolic pathways. Although current evidence remains heterogeneous and largely derived from preclinical and observational studies, the microbiota emerges not only as a potential therapeutic target but as a key integrative node linking endocrine, immune, and metabolic pathways in endometriosis. Future research should focus on well-designed clinical trials to validate microbiome-based interventions and to define their role in personalized management strategies for endometriosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400015 Cluj-Napoca, Romania.
- 2nd Department of Faculty of Nursing and Health Sciences, "Iuliu Hațieganu" University of Medicine and Pharmacy, 2-4 Clinicilor St., 400006 Cluj-Napoca, Romania.
- Department of Diabetes and Nutrition Diseases, Emergency Clinical County Hospital Cluj, 400006 Cluj-Napoca, Romania.
- Department of Pharmacology, Toxicology and Clinical Pharmacology, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.
- Discipline of Histology, Department of Morpho-Functional Sciences, "Iuliu Hațieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.
- Department of Healthcare-Associated Infections, Emergency Clinical County Hospital Cluj, 400006 Cluj-Napoca, Romania.
ORCID-Profile: Georgiana Nemeti, Dan Claudiu Măgureanu, Ioana Corina Bocsan, Adriana Rusu, Anca Dana Buzoianu, Maria Adriana Neag
Zitieren
APA
Nemeti, G., Crăciun, A. E., Măgureanu, D. C., Militaru, F. C., Bocsan, I. C., Crăciun, C. I., Rusu, A., Melincovici, C. S., Buzoianu, A. D., Mureșan, D., & Neag, M. A. (2026). The Microbiota–Endometriosis Axis: An Immune–Endocrine Integration Model and Emerging Therapeutic Targets. International Journal of Molecular Sciences, 27(11), 4883. https://doi.org/10.3390/ijms27114883
Vancouver
Nemeti G, Crăciun AE, Măgureanu DC, Militaru FC, Bocsan IC, Crăciun CI, et al. The Microbiota–Endometriosis Axis: An Immune–Endocrine Integration Model and Emerging Therapeutic Targets. International Journal of Molecular Sciences. 2026;27(11):4883. doi:10.3390/ijms27114883
BibTeX
@article{Nemeti2026,
author = {Nemeti, Georgiana and Crăciun, Anca Elena and Măgureanu, Dan Claudiu and Militaru, Florentina Claudia and Bocsan, Ioana Corina and Crăciun, Cristian-Ioan and Rusu, Adriana and Melincovici, Carmen Stanca and Buzoianu, Anca Dana and Mureșan, Daniel and Neag, Maria Adriana},
title = {The Microbiota–Endometriosis Axis: An Immune–Endocrine Integration Model and Emerging Therapeutic Targets},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {11},
pages = {4883},
doi = {10.3390/ijms27114883}
}
EUVIMED